C Kim1, C A Christophi2, R B Goldberg3, L Perreault4, D Dabelea5, S M Marcovina6, X Pi-Sunyer7, E Barrett-Connor8. 1. Departments of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA. 2. Biostatistics Center, George Washington University, Rockville, MD, USA. 3. Department of Medicine, University of Miami, Miami, FL, USA. 4. Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 5. Department of Preventive Medicine and Biometrics, Colorado School of Public Health, Aurora, CO, USA. 6. Department of Medicine, University of Washington, Seattle, WA, USA. 7. Division of Endocrinology, Columbia University Medical Center, New York City, NY, USA. 8. Department of Family and Preventive Medicine, University of California, San Diego, CA, USA.
Abstract
AIM: To examine concentrations of biomarkers (adiponectin, C-reactive protein, fibrinogen and tissue plasminogen-activator antigen) associated with glucose homeostasis and diabetes risk by history of gestational diabetes (GDM). METHODS: We conducted a secondary analysis of the Diabetes Prevention Program, a randomized trial of lifestyle intervention or metformin for diabetes prevention. At baseline, participants were overweight and had impaired glucose tolerance. Biomarkers at baseline and 1 year after enrolment were compared between parous women with (n = 350) and without histories of GDM (n = 1466). Cox proportional hazard models evaluated whether history of GDM was associated with diabetes risk, after adjustment for baseline biomarker levels as well as for change in biomarker levels, demographic factors and anthropometrics. RESULTS: At baseline, women with histories of GDM had lower adiponectin (7.5 μg/ml vs. 8.7 μg/ml; p < 0.0001) and greater log C-reactive protein (-0.90 mg/l vs. -0.78 mg/l, p = 0.04) levels than women without histories of GDM, but these associations did not persist after adjustment for demographic factors. Fibrinogen and tissue plasminogen-activator antigen were similar between women with and without histories of GDM. Women with and without histories of GDM had a similar pattern of changes in biomarkers within randomization arm. Adjustment for age, race/ethnicity, baseline weight, change in weight, baseline biomarker level and change in biomarker level did not significantly alter the association between history of GDM, and diabetes risk. CONCLUSIONS: Among women with impaired glucose tolerance, biomarkers in women with and without histories of GDM are similar and respond similarly to lifestyle changes and metformin. Adjustment for biomarker levels did not explain the higher risk of diabetes observed in women with histories of GDM.
RCT Entities:
AIM: To examine concentrations of biomarkers (adiponectin, C-reactive protein, fibrinogen and tissue plasminogen-activator antigen) associated with glucose homeostasis and diabetes risk by history of gestational diabetes (GDM). METHODS: We conducted a secondary analysis of the Diabetes Prevention Program, a randomized trial of lifestyle intervention or metformin for diabetes prevention. At baseline, participants were overweight and had impaired glucose tolerance. Biomarkers at baseline and 1 year after enrolment were compared between parous women with (n = 350) and without histories of GDM (n = 1466). Cox proportional hazard models evaluated whether history of GDM was associated with diabetes risk, after adjustment for baseline biomarker levels as well as for change in biomarker levels, demographic factors and anthropometrics. RESULTS: At baseline, women with histories of GDM had lower adiponectin (7.5 μg/ml vs. 8.7 μg/ml; p < 0.0001) and greater log C-reactive protein (-0.90 mg/l vs. -0.78 mg/l, p = 0.04) levels than women without histories of GDM, but these associations did not persist after adjustment for demographic factors. Fibrinogen and tissue plasminogen-activator antigen were similar between women with and without histories of GDM. Women with and without histories of GDM had a similar pattern of changes in biomarkers within randomization arm. Adjustment for age, race/ethnicity, baseline weight, change in weight, baseline biomarker level and change in biomarker level did not significantly alter the association between history of GDM, and diabetes risk. CONCLUSIONS: Among women with impaired glucose tolerance, biomarkers in women with and without histories of GDM are similar and respond similarly to lifestyle changes and metformin. Adjustment for biomarker levels did not explain the higher risk of diabetes observed in women with histories of GDM.
Authors: S Bo; A Signorile; G Menato; R Gambino; C Bardelli; M L Gallo; M Cassader; M Massobrio; G F Pagano Journal: J Endocrinol Invest Date: 2005-10 Impact factor: 4.256
Authors: A Di Benedetto; G T Russo; F Corrado; E Di Cesare; E Alessi; G Nicocia; R D'Anna; D Cucinotta Journal: J Endocrinol Invest Date: 2005-01 Impact factor: 4.256
Authors: Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reuben Andres; Christopher Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon Journal: Diabetes Date: 2005-08 Impact factor: 9.461
Authors: G Di Cianni; C Lencioni; L Volpe; A Ghio; I Cuccuru; G Pellegrini; L Benzi; R Miccoli; S Del Prato Journal: Diabetes Metab Res Rev Date: 2007-02 Impact factor: 4.876
Authors: Steven Haffner; Marinella Temprosa; Jill Crandall; Sarah Fowler; Ronald Goldberg; Edward Horton; Santica Marcovina; Kieren Mather; Trevor Orchard; Robert Ratner; Elizabeth Barrett-Connor Journal: Diabetes Date: 2005-05 Impact factor: 9.461
Authors: Christos S Mantzoros; Tricia Li; JoAnn E Manson; James B Meigs; Frank B Hu Journal: J Clin Endocrinol Metab Date: 2005-05-24 Impact factor: 5.958
Authors: Tânia B Ferraz; Rosa S Motta; Camila Lousada Ferraz; Diego Moreira Capibaribe; Adriana C Forti; Antônio R Chacra Journal: Diabetes Res Clin Pract Date: 2007-04-20 Impact factor: 5.602
Authors: Pandora L Wander; Costas A Christophi; Maria Rosario G Araneta; Edward J Boyko; Daniel A Enquobahrie; Dana Dabelea; Ronald B Goldberg; Steven E Kahn; Catherine Kim; Xavier Pi-Sunyer; William C Knowler Journal: Obesity (Silver Spring) Date: 2021-11-18 Impact factor: 5.002
Authors: Sadia Mehmood; Chang Ye; Philip W Connelly; Anthony J Hanley; Bernard Zinman; Ravi Retnakaran Journal: Cardiovasc Diabetol Date: 2018-10-09 Impact factor: 9.951